Commercial — with coverage
Afrezza Savings Card — commercial insurance
- Monthly max
- $2,000
- Annual max
- —
- Fills / year
- —
Pay as little as $35 per fill, up to a $2,000/month benefit. Commercial / employer plans only.
MannKind
Afrezza is inhaled insulin. Commercially-insured patients pay as little as $35 per fill (up to $2,000/mo) with the Afrezza Savings Card; uninsured/cash patients can use MannKind’s Direct Purchase Program for about $99/mo.
What you need to enroll
Instant card — no doctor needed to enroll
Sign up on the manufacturer's site in about 2 minutes. You don't need a doctor visit to get the card itself — just bring it to your pharmacy with your prescription at fill time.
Your estimated copay
This program publishes different cards depending on your insurance situation.
Commercial — with coverage
Pay as little as $35 per fill, up to a $2,000/month benefit. Commercial / employer plans only.
Accepted
Not accepted
For commercial insurance, run the Afrezza Savings Card BIN/PCN/Group to bring the copay to as low as $35 (up to $2,000/mo). Uninsured patients use the Direct Purchase Program (~$99/mo) instead.
Per-card-type caps may vary — see the variants above for details.
Inhaled human insulin (technosphere) from MannKind for adults and children 6+. Three paths: (1) Commercial insurance — Afrezza Savings Card, pay as little as $35/fill up to a $2,000/month benefit; (2) Cash / uninsured — Direct Purchase Program, ~$99/month; (3) Medicare — under the Inflation Reduction Act, a $35/month max copay applies if the plan covers Afrezza (the savings card itself is not valid for Medicare/Medicaid/VA/DOD/TRICARE). Must be used with a basal insulin in type 1.
Be first when we launch — we'll save these matches and remind you to renew.
Join the waitlist